INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis
-
(2015/05/19)
HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors.
-
Paragraph 0180-0183
(2014/07/08)
HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors.
-
Page/Page column 21
(2013/04/10)
Process for producing an intermediate of a new quinolone compound
A production process with good efficiency, and applicable to production of a synthetic intermediate of a new quinolone anti-fungus agent CP-99219, is provided. A production process of an intermediate of a new quinolone compound expressed by the formula (I
-
(2008/06/13)
More Articles about upstream products of 186376-30-7